A Translational Model for Repeated Episodes of Joint Inflammation: Welfare, Clinical and Synovial Fluid Biomarker Assessment.
Authors: Kearney Clodagh M, Korthagen Nicoline M, Plomp Saskia G M, Labberté Margot C, de Grauw Janny C, van Weeren P René, Brama Pieter A J
Journal: Animals : an open access journal from MDPI
Summary
# Editorial Summary Recurrent joint inflammation represents a significant clinical challenge in equine practice, yet translational models remain limited for studying how repeated inflammatory episodes affect cartilage integrity and synovial homeostasis. Researchers induced controlled inflammation in eight horses using three intra-articular injections of low-dose lipopolysaccharide (0.25 ng) at two-week intervals, monitoring clinical signs, welfare indicators, and a comprehensive panel of synovial fluid biomarkers including matrix metalloproteinase activity, glycosaminoglycans, and type II collagen breakdown products over 168 hours post-injection and again eight weeks later. Each injection elicited reproducible inflammatory and biochemical responses; notably, the second injection provoked exaggerated increases in general MMP activity and joint circumference, whilst GAG concentrations showed progressively blunted responses across successive injections, suggesting potential adaptation or depletion mechanisms. Collagen degradation markers (C2C and CPII) demonstrated earlier and more pronounced responses to subsequent inductions, indicating altered cartilage turnover kinetics with repeat exposure. By eight weeks post-final injection, all parameters normalised to baseline levels with minimal welfare compromise throughout, establishing this protocol as a refined model for investigating recurrent joint inflammation without significant animal harm. For practitioners managing horses with recurrent synovitis or traumatic arthritis, these findings provide insight into how cartilage responds biochemically to repeated inflammatory insults and may inform evidence-based management strategies aimed at disrupting maladaptive remodelling patterns before structural damage becomes irreversible.
Read the full abstract on PubMed
Practical Takeaways
- •This model demonstrates that horses tolerate repeated controlled joint inflammation with minimal welfare consequences, providing a reliable research tool for studying recurrent joint disease mechanisms.
- •The differential biomarker responses across repeated insults suggest that cartilage adaptation occurs with recurrent inflammation, which may inform understanding of how equine joints respond to repeated trauma or infection in clinical practice.
- •Recovery to baseline parameters by 8 weeks post-final injection indicates that single episodes of LPS-induced inflammation do not appear to cause lasting joint damage in this model, though clinical relevance to naturally occurring recurrent joint disease requires further validation.
Key Findings
- •Repeated intra-articular LPS injections (0.25 ng at 2-week intervals) produced consistent clinical and biomarker responses across three inductions with minimal welfare impact.
- •General MMP activity and joint circumference showed greater response to the second LPS injection, but third injection response was comparable to the first.
- •GAG levels showed significantly decreased response with each successive induction, while C2C and CPII showed quicker responses to second and third injections.
- •All clinical parameters and biomarkers returned to baseline values 8 weeks after the final injection, indicating recovery of normal joint homeostasis.